Pamela Riemer

Berlin, BE 10117, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Transcriptomic Deconvolution of Neuroendocrine Neoplasms Predicts Clinically Relevant Characteristics.

Transcriptomic Deconvolution of Neuroendocrine Neoplasms Predicts Clinically Relevant Characteristics.

Journal: Cancers
Published: November 11, 2022

Elevated Flt3L Predicts Long-Term Survival in Patients with High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms.

Elevated Flt3L Predicts Long-Term Survival in Patients with High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms.

Journal: Cancers
Published: July 22, 2021

DNA methylation reveals distinct cells of origin for pancreatic neuroendocrine carcinomas and pancreatic neuroendocrine tumors.

DNA methylation reveals distinct cells of origin for pancreatic neuroendocrine carcinomas and pancreatic neuroendocrine tumors.

Journal: Genome medicine
Published: May 21, 2021

SFPQ Depletion Is Synthetically Lethal with BRAFV600E in Colorectal Cancer Cells.

SFPQ Depletion Is Synthetically Lethal with BRAFV600E in Colorectal Cancer Cells.

Journal: Cell reports
Published: October 05, 2019

Prognostic value and association with epithelial-mesenchymal transition and molecular subtypes of the proteoglycan biglycan in advanced bladder cancer.

Prognostic value and association with epithelial-mesenchymal transition and molecular subtypes of the proteoglycan biglycan in advanced bladder cancer.

Journal: Urologic oncology
Published: August 15, 2018

Cell type-dependent differential activation of ERK by oncogenic KRAS in colon cancer and intestinal epithelium.

Cell type-dependent differential activation of ERK by oncogenic KRAS in colon cancer and intestinal epithelium.

Journal: Nature communications
Published: June 06, 2018

Controlled re-activation of epigenetically silenced Tet promoter-driven transgene expression by targeted demethylation.

Controlled re-activation of epigenetically silenced Tet promoter-driven transgene expression by targeted demethylation.

Journal: Nucleic acids research
Published: December 11, 2016

Oncogenic β-catenin and PIK3CA instruct network states and cancer phenotypes in intestinal organoids.

Oncogenic β-catenin and PIK3CA instruct network states and cancer phenotypes in intestinal organoids.

Journal: The Journal of cell biology
Published: October 18, 2016

Oncogenic Ras triggers hyperproliferation and impairs polarized colonic morphogenesis by autocrine ErbB3 signaling.

Oncogenic Ras triggers hyperproliferation and impairs polarized colonic morphogenesis by autocrine ErbB3 signaling.

Journal: Oncotarget
Published: January 31, 2016

Cell hierarchies in colorectal cancer: focus on APC and BRAF.

Cell hierarchies in colorectal cancer: focus on APC and BRAF.

Journal: Oncoscience
Published: July 10, 2015

Similar but different: distinct roles for KRAS and BRAF oncogenes in colorectal cancer development and therapy resistance.

Similar but different: distinct roles for KRAS and BRAF oncogenes in colorectal cancer development and therapy resistance.

Journal: Oncotarget
Published: May 07, 2015

Transgenic expression of oncogenic BRAF induces loss of stem cells in the mouse intestine, which is antagonized by β-catenin activity.

Transgenic expression of oncogenic BRAF induces loss of stem cells in the mouse intestine, which is antagonized by β-catenin activity.

Journal: Oncogene
Published: March 03, 2014
Showing 1-12 of 14

Last Updated: 09/26/2026